Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canopy Growth Corp (NQ: CGC )

3.900 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.900
Bid (Size) 3.870 (1)
Ask (Size) 3.930 (17)
Prev. Close 3.900
Today's Range 3.900 - 3.900
52wk Range 2.755 - 14.92
Shares Outstanding 586,619,644
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Maryland Starts Using Dashboard for Tracking Marijuana Use
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
What's Happening With Canopy Growth: Is It Time To Buy?
Canopy Growth (NASDAQ: CGC) hovers near $3.93. Fibonacci levels suggest key resistance at $6.36 and support at $3.86. Is it worth the risk? 
Via Benzinga

Performance

YTD
-18.58%
-18.58%
1 Month
-28.31%
-28.31%
3 Month
-36.79%
-36.79%
6 Month
-54.01%
-54.01%
1 Year
-28.73%
-28.73%

More News

Read More
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canopy Growth's Earnings Outlook
Via Benzinga
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY
Via Benzinga
Topics Cannabis
Exposures Cannabis
New Research Finds Marijuana Use Lowers Opioid and Alcohol Consumption
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Nov 11
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Canopy Growth (CGC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead
Via Benzinga
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
Via Benzinga
Cannabis Stock Gainers And Losers From November 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures
Via Benzinga
Topics Cannabis
Exposures Cannabis
Multistate Operators and Their Contribution to the Marijuana Industry
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 31, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 30, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — NIH Says Oncologists Aren’t Equipped to Answer Cancer Patients’ Questions on Medical Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.